Five Prime Therapeutics CEO Aron Knickerbocker's 2019 pay jumps 262% to $7.5M
Five Prime Therapeutics reports 2019 executive compensation
By ExecPay News
Published: April 3, 2020
Five Prime Therapeutics reported fiscal year 2019 executive compensation information on April 3, 2020.
In 2019, four executives at Five Prime Therapeutics received on average a compensation package of $2.9M, a 122% increase compared to previous year.
Average pay of disclosed executives at Five Prime Therapeutics
Aron M. Knickerbocker, Chief Executive Officer, received $7.5M in total, which increased by 262% compared to 2018.
Helen Collins, Chief Medical Officer, received a compensation package of $1.6M, which increased by 20% compared to previous year. 31% of the compensation package, or $504K, was in option awards.
Francis W. Sarena, Secretary, earned $1.5M in 2019, a 16% increase compared to previous year.
William R. Ringo, Chief Executive Officer, received $864K in 2019.
Related executives
You may also like
Source: SEC filing on April 3, 2020.